Copyright: ©Author(s) 2026.
World J Cardiol. Jul 26, 2026; 18(7): 121228
Published online Jul 26, 2026. doi: 10.4330/wjc.121228
Published online Jul 26, 2026. doi: 10.4330/wjc.121228
Table 1 Baseline demographic, clinical, and echocardiographic characteristics of the study cohort (n = 28)
| Variable | Total (n = 28) | Survivors (n = 24) | Non-survivors (n = 4) | P value |
| Age (years) | 73.82 ± 12.14 | 74.12 ± 11.68 | 72.00 ± 16.57 | 0.819 |
| Male sex, % | 61.9 | 64.7 | 50.0 | 0.618 |
| Smoking, % | 21.4 | 20.8 | 25.0 | 1.000 |
| Hypertension, % | 100.0 | 100.0 | 100.0 | 1.000 |
| Dyslipidemia, % | 96.4 | 100.0 | 75.0 | 0.143 |
| Obesity, % | 29.6 | 30.4 | 25.0 | 1.000 |
| Diabetes mellitus, % | 53.6 | 50.0 | 75.0 | 0.600 |
| Valvular heart disease, % | 71.4 | 75.0 | 50.0 | 0.555 |
| Systolic BP (mmHg) | 173.39 ± 38.52 | 172.58 ± 39.94 | 178.25 ± 33.05 | 0.772 |
| Diastolic BP (mmHg) | 99.39 ± 21.23 | 99.75 ± 22.59 | 97.25 ± 11.70 | 0.746 |
| Heart rate (bpm) | 105.61 ± 23.04 | 105.75 ± 24.69 | 104.75 ± 10.24 | 0.892 |
| NT-proBNP (pg/mL) | 10513.96 ± 10381.23 | 9955.83 ± 10293.27 | 13862.75 ± 11840.24 | 0.569 |
| TAPSE (mm) | 22.61 ± 8.20 | 23.29 ± 8.61 | 18.50 ± 3.32 | 0.072 |
| LVOT VTI (cm) | 16.20 ± 4.52 | 16.03 ± 4.72 | 17.23 ± 3.34 | 0.561 |
| RV-RA gradient (mmHg) | 28.93 ± 9.74 | 29.00 ± 10.51 | 28.50 ± 2.65 | 0.845 |
| LVEF (%) | 38.68 ± 15.42 | 38.83 ± 15.07 | 37.75 ± 19.92 | 0.923 |
Table 2 Comparison of echocardiographic parameters between survivors and non-survivors with cardiogenic pulmonary edema
| Parameter | Survivors, median (IQR) | Non-survivors, median (IQR) | P value |
| E/E’ | 11.37 (10.15-14.33) | 15.41 (12.70-18.17) | 0.291 |
| TAPSE | 20.00 (17.75-26.25) | 19.00 (17.75-19.75) | 0.323 |
| S RV | 12.00 (10.00-13.20) | 10.00 (8.25-11.75) | 0.339 |
| S LV | 6.90 (5.97-7.62) | 6.75 (6.12-7.12) | 0.669 |
| S LV/S RV | 0.60 (0.50-0.71) | 0.73 (0.59-0.83) | 0.533 |
| LVEF | 37.50 (26.75-47.25) | 38.00 (20.75-55.00) | 0.844 |
| LVOT VTI | 16.00 (13.38-18.25) | 17.00 (14.72-19.50) | 0.645 |
Table 3 Echocardiographic parameters according to ventilatory support requirements (n = 28)
| Parameter | No ventilation, median (IQR) | NIV, median (IQR) | IMV, median (IQR) | P value |
| TAPSE | 19.00 (15.75-28.00) | 20.00 (17.50-24.00) | 20.50 (17.75-23.25) | 0.916 |
| S RV | 12.35 (10.50-13.60) | 11.70 (9.00-12.20) | 11.45 (9.75-12.43) | 0.483 |
| S LV | 6.70 (5.83-8.20) | 7.00 (6.00-7.75) | 6.75 (6.12-7.05) | 0.683 |
| S LV/S RV | 0.62 (0.48-0.73) | 0.62 (0.52-0.80) | 0.62 (0.57-0.69) | 0.865 |
| RV-RA gradient | 31.0 (17.75-40.25) | 29.0 (21.50-34.50) | 29.5 (26.75-35.50) | 0.816 |
| E/E’ | 12.29 (10.89-15.48) | 11.44 (9.97-13.92) | 13.61 (9.85-18.17) | 0.680 |
| LVOT VTI | 16.40 (13.55-21.75) | 15.00 (13.50-18.50) | 15.75 (14.72-17.62) | 0.800 |
| LVEF | 38.0 (27.25-54.00) | 38.0 (30.50-45.00) | 28.0 (20.75-40.00) | 0.580 |
Table 4 Spearman correlation analysis between echocardiographic parameters and intensive care unit length of stay
| Parameter | Spearman ρ | P value |
| TAPSE | -0.148 | 0.444 |
| S RV | -0.078 | 0.686 |
| S LV | -0.189 | 0.326 |
| S LV/S RV | -0.001 | 0.995 |
| RV-RA gradient | -0.055 | 0.777 |
| E-wave | 0.175 | 0.363 |
| E/E’ | 0.198 | 0.302 |
| LVOT VTI | 0.031 | 0.874 |
| LVEF | -0.175 | 0.365 |
Table 5 Echocardiographic parameters according to inotropic support requirement
| Parameter | No inotrope, median (IQR) | Inotrope, median (IQR) | P value |
| E/E’ | 12.02 (10.62-14.33) | 13.61 (9.38-18.17) | 0.874 |
| TAPSE (mm) | 19.50 (17.75-26.25) | 19.50 (17.75-20.50) | 0.448 |
| S RV (cm/second) | 12.00 (10.00-13.20) | 10.00 (8.25-11.75) | 0.339 |
| S LV (cm/second) | 6.90 (5.97-7.50) | 6.75 (6.12-8.00) | 0.973 |
| S LV/S RV | 0.60 (0.50-0.71) | 0.73 (0.59-0.93) | 0.393 |
| LVEF (%) | 38.50 (26.75-52.00) | 29.50 (20.75-42.25) | 0.449 |
| LVOT VTI (cm) | 16.20 (13.38-19.00) | 14.50 (13.97-16.50) | 0.792 |
- Citation: Popescu DC, Diaconu M, Țînț D, Nechita AC. Left and right ventricular echocardiographic patterns in cardiogenic pulmonary edema: An exploratory retrospective study. World J Cardiol 2026; 18(7): 121228
- URL: https://www.wjgnet.com/1949-8462/full/v18/i7/121228.htm
- DOI: https://dx.doi.org/10.4330/wjc.121228